Geoffrey Owen Littlejohn

17PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityOrthopticsClinical pharmacology and therapeuticsRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 13, 2025
Correction: Real‑World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis.

Peter Youssef, Sabina Ciciriello, Talib Tahir

|Feb 26, 2025
Neuroinflammatory and Immunological Aspects of Fibromyalgia.

Kate Findeisen, Emma Guymer, Geoffrey Littlejohn

|Feb 05, 2025
The Relationship Between Patient-Reported Quality of Life and Physician-Derived Clinical Outcomes in Rheumatoid Arthritis in the Australian OPAL Dataset.

Geoffrey Littlejohn, Nithila Anbumurali, Catherine O'Sullivan

|Jan 05, 2025
Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis.

Peter Youssef, Sabina Ciciriello, Talib Tahir

|Apr 18, 2024
Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.

Geoffrey Littlejohn, Nithila Anbumurali, Catherine O'Sullivan

|Mar 08, 2024
Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia.

Geoffrey Littlejohn, Joanna Leadbetter, Belinda E Butcher

Pageof 3

Frequent Collaborators

7 joint publications

Tegan Smith

7 joint publications

Catherine O'Sullivan

5 joint publications

Paul Bird

5 joint publications

Hedley Griffiths